Study shows Copaxone reduces "black holes" in the brain. (News).A study published in the August 28, 2001 issue of Neurology clinical neurology that especially concerned with the diagnosis and treatment of disorders of the nervous system. neu·rol·o·gy (n  -r l showed that Copaxone (glatiramer glatiramer /gla·tir·a·mer/ (glah-tir´ah-mer) an immunomodulator used as the acetate ester to reduce relapses in multiple sclerosis. acetate for injection) reduced the number of permanent "black holes" that developed in people with relapsing-remitting MS. These lesions are believed to represent areas where nerve loss--the most severe and irreversible brain tissue damage in MS--has occurred. The seven-month study, headed by Massimo Filippi, MD, head of the Neuroimaging Research Unit at the Scientific Institute and the University Ospedale San Raffaele, Milan, Italy, evaluated 239 people with MS. Half of the participants were given Copaxone; the other half were given an inert placebo. An earlier study published in the July 25, 2000 issue of Neurology showed that Avonex (interferon betala) can also slow accumulation of black holes. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion